Allergy/Immunology Update 2024

Dates and Times

Start: 6/19/2024 8:00 AM
End: 6/19/2024 9:30 AM

Objectives

1. To discuss recent developments in food allergy, including the approval of omalizumab for use in food allergy and long-term follow-up of the LEAP study (Learning Early about Peanut)

2. To familiarize audience with the use of novel delivery systems for epinephrine in anaphylaxis and the increased availability of stock epinephrine in public venues and airplanes.

3. To describe newly approved medications for Eosinophilic Esophagitis.

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.